印度全球疫苗高峰会2013 （Vaccine World Summit India 2013 ）

• 会议名称： Vaccine World Summit India 2013 印度全球疫苗高峰会2013
• 会议时间： 2013年3月5日至2013年3月7日
• 会议地点： 印度 . 浦那，Westin Pune Koregaon Park
• 主办单位： IMAPAC
• 官方网站： http://www.imapac.com/index.php?page=VaccineWorldSummitIndia2013

行业领域： 疫苗产业、生物制药

会议类型： 高峰会、行业会议、研讨会

会议主题： 探索疫苗生命周期各阶段的合作机会，从基础研究到生产、许可等各个方面

• 早期折扣截止日期： 2013年1月31日
• 联系信息：
  • 邮件：info@imapac.com
  • 电话：+65 6493 2097

Dr Suresh Jadhav, Executive Director, Serum Institute, India Dr Rajiv Indravadan Modi, Director/Managing Director, Cadila Pharmaceuticals, India Dr Inderjit Singh Sarao, Associate Director, Merck, USA Dr James F. Young, Chairman, Novavax, USA Dr Harish Iyer, CEO, Shantha Biotechnics, India Dr Norman Baylor, Advisor, PATH MVI Vaccine Science Portfolio Advisory Council (VSPAC), USA Dr Ranga Iyer, Advisor, Indian Health Progress & Global Pharma Associations, India Dr Raj Shankar Ghosh, Technical Director, PATH , India Dr Stanley Erck, President and CEO, Novavax, USA Dr Anand Kumar, Deputy Managing Director, Indian Immunologicals, India Dr V. Krishna Mohan, Executive Director, Bharat Biotech International, India Dr SD Ravetkar, Executive Director, Serum Institute, India Dr Reinhard Glueck, Chief Scientific Officer, Zydus Cadila, India Dr Shirshendu Mukherjee, Senior Strategic Advisor, Wellcome Trust, India Dr Davinder Gill, Chief Executive Officer, MSD Wellcome Trust Hilleman Laboratories, India Dr Ramesh S. Paranjape, Director, National AIDS Research Institute, India Dr Vipin Vashishtha, Convener, Indian Academy of Pediatrics - Committee on Immunization, India Helen Yang, Business Development Director, Sinovac Biotech, China Dr Sanjay Singh, Chairman, Gennova Biopharma, India Dr Jacqui Shea, General Manager, Oxford-Emergent Tuberculosis Consortium, UK Abdul Muktadir, Managing Director, Incepta, Bangladesh Dr Rajendra Jani, Senior Vice President of Clinical R&D, Cadila Healthcare, India Dr Gregory Glenn, Senior VP and CMO, Novovax Dr Ashish Bavdekar, President, IAP - Gastroenterology Chapter Ashish Kenneth Kelley, Co-Founder, CEO, Executive Chairman, PaxVax Prof T Jacob John, Virologist, Christian Medical College in Vellore, WHO Committee Global Polio Eradication, India Dr Shailesh Mehta, Medical Director of Clinical R&D (Medical Affairs Biologics - South Asia),GSK Dr Ramesh Matur, General Manager of R&D, Indian Immunologicals Dr Sudhakar Konda, Vice President, One Stream R&D (Panacea) Dr Steve Whitehead, Head of Dengue Project, Laboratory of Infectious Diseases of NIH Dr Subhra Chakrabarti, Head of Manufacturing Technology, Shantha Biotechnics Dr Rakesh Sinha, General Manager and Project Director of JE Vaccine, Biological E. Dr Nathelie Garcon, Vice President and Head of Global Adjuvant Centre for Vaccine Development,GSK Biologicals Dr Anuj Walia, Regional Director of Medical Affairs, MSD Pharmaceuticals Dr Alfred Luitjens, Early Stage Development Leader for the Inactivated Polio Project and Senior Scientist, Crucell